PillRx only · Solution · Nasal
Desmopressin Acetate
Desmopressin Acetate
2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US2 NDCs
2 active makers
2 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC—
RxCUI (US)—
US makers2 labelers
Packages2
DEA / ScheduleNone
US acquisition costNADAC · per unit
Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$23.917
Latest avg · Feb 18, 2026
+2%
Since Dec 17, 2025
2
Active US suppliers
100%
Top-2 supplier share*
Who makes it2 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Bausch & Lomb Incorporated | unknown | 1 | SUPPLYING |
| Oceanside Pharmaceuticals | unknown | 1 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.